Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial.

MLA

Kovacs, Boldizsar, et al. “Dose Escalation for Stereotactic Arrhythmia Radioablation of Recurrent Ventricular Tachyarrhythmia - a Phase II Clinical Trial.” Radiation Oncology, vol. 18, no. 1, Nov. 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13014-023-02361-x.

APA

Kovacs, B., Mayinger, M., Ehrbar, S., Fesslmeier, D., Ahmadsei, M., Sazgary, L., Manka, R., Alkadhi, H., Ruschitzka, F., Duru, F., Papachristofilou, A., Sticherling, C., Blamek, S., Gołba, K. S., Guckenberger, M., Saguner, A. M., & Andratschke, N. (2023). Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial. Radiation Oncology, 18(1), 1–8. https://doi.org/10.1186/s13014-023-02361-x

Chicago

Kovacs, Boldizsar, Michael Mayinger, Stefanie Ehrbar, Debra Fesslmeier, Maiwand Ahmadsei, Lorraine Sazgary, Robert Manka, et al. 2023. “Dose Escalation for Stereotactic Arrhythmia Radioablation of Recurrent Ventricular Tachyarrhythmia - a Phase II Clinical Trial.” Radiation Oncology 18 (1): 1–8. doi:10.1186/s13014-023-02361-x.